BlackRock, Inc. 13D and 13G filings for Vertex Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX | BlackRock Inc. BLK | 21,881,203 8.500% | -2,360,234 (-9.74%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX | BlackRock Inc. BLK | 24,241,437 9.400% | 296,506 (+1.24%) | Filing |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX | BlackRock Inc. BLK | 23,944,931 9.400% | -323,964 (-1.33%) | Filing |
| 2021-02-01 08:23 am Purchase | 2020-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX | BlackRock Inc. BLK | 24,268,895 9.300% | 3,152,074 (+14.93%) | Filing |
| 2020-02-06 09:10 am Purchase | 2019-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX | BlackRock Inc. BLK | 21,116,821 8.200% | 1,509,011 (+7.70%) | Filing |